Screening device precisely identifies amblyopia in NIH-funded study
The device detected all six cases of amblyopia and/or strabismus in children aged two to six years.

The device detected all six cases of amblyopia and/or strabismus in children aged two to six years.
Through the deal, AXIM will obtain two US FDA-approved ophthalmic diagnostic lab tests to detect biomarkers for dry eye disease.
Leveraging WHITESTAR technology, along with elliptical tip movement, the VERITAS Vision System allows smoother cutting.
The latest test is carried out with a blood or saliva sample to potentially detect the disease prior to irreversible…
Intended for treating primary open-angle glaucoma, MINIject can potentially lower intraocular pressure.
PDS is a permanent, refillable eye implant that can deliver continuous doses of ranibizumab for up to six months.
PRESERFLO MicroShunt is designed to allow draining of eye fluid and lowering of IOP in primary open-angle glaucoma patients.
Johnson & Johnson Vision’s overnight therapeutic lenses receive FDA approval for myopia.
Thank you for subscribing to Medical Device Network